CN110464832A - A kind of polypeptide nursing bacteriostatic gel - Google Patents
A kind of polypeptide nursing bacteriostatic gel Download PDFInfo
- Publication number
- CN110464832A CN110464832A CN201910893852.0A CN201910893852A CN110464832A CN 110464832 A CN110464832 A CN 110464832A CN 201910893852 A CN201910893852 A CN 201910893852A CN 110464832 A CN110464832 A CN 110464832A
- Authority
- CN
- China
- Prior art keywords
- peptide
- nursing
- matrine
- bacteriostatic gel
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Abstract
The present invention provides a kind of polypeptides to nurse bacteriostatic gel, belongs to bacteriostatic gel field.Its technical solution are as follows: be prepared by the component of following quality proportionings: matrine 0.2%~0.5%, glucan 0.2%~0.5%, biological peptide 0.1%~0.4%, hydrolyzed pearl solution 0.01%~0.04%, bioprotein peptide 0.1%~0.4%, glue peptide silver 0.2-0.3 ‰, palmityl tripeptides -1 0.01%~0.04%, biotin tripeptides -10.1%~0.04%, yeast polypeptides 0.2%~0.5%, auxiliary material: mountain potassium phosphate 0.05-0.3%, card pool nurse 0.2%~0.5%.The invention has the benefit that the present invention is combined using matrine with a variety of biological peptides, can Fast-Balance vaginal pH, analgesia goes to itch, it is daily moisten, compact vagina, efficiently maintenance, the dynamic equilibrium for adjusting reproductive system effectively prevents the effect of various gynaecological imflammations, and is easily absorbed by the human body.
Description
Technical field
The present invention relates to a kind of bacteriostatic gel fields more particularly to a kind of polypeptide to nurse bacteriostatic gel.
Background technique
Feminine care products are common nursing materials in a kind of daily life, and primary efficacy is to adjust ph value, sterilization
And cleaning, feminine care products currently on the market mainly have the disadvantage that: being chiefly used in treating, be not suitable for daily maintenance；
Artificial essence is largely added, privates skin is destroyed；Time of contact is short, is easy to run off, and carries, is inconvenient to use, and negative using being easy
Road mucous membrane is impaired, causes intravaginal glycogen to be lost and destroys ph balancing, and mucous membrane loses itself resistance, and gynaecological problem just can be anti-
It is repeatedly multiple.
Matrine clinically can be used for the diseases such as skin disease, gynaecology and men and women's venereal disease, now widely used with kuh-seng
Bases alkaloid is that the external preparation of active pharmaceutical ingredient is usually solution and vaginal suppository, and conventional dosage forms are in actual use
There is affected part action time it is short, be unfavorable for effective component and play a role or the defects of inconvenient for use, patient's poor compliance.
Summary of the invention
It is combined using matrine with a variety of biological peptides the purpose of the present invention is to provide a kind of, it being capable of Fast-Balance vagina
PH value, analgesia go to itch, and daily to moisten, compact vagina, efficiently maintain, the dynamic equilibrium for adjusting reproductive system effectively prevents various woman
The effect of section's inflammation, and the polypeptide nursing bacteriostatic gel being easily absorbed by the human body.
The present invention is realized by following measure:
A kind of polypeptide nursing bacteriostatic gel, which is characterized in that nursing bacteriostatic gel is prepared by the component of following quality proportionings:
Matrine 0.2%~0.5%, glucan 0.2%~0.5%, biological peptide 0.1%~0.4%, hydrolyzed pearl solution 0.01%~0.04%, life
Object protein peptides 0.1%~0.4%, glue peptide silver 0.2-0.3 ‰, palmityl tripeptides -1 0.01%~0.04%, biotin tripeptides -10.1%
~0.04%, yeast polypeptides 0.2%~0.5%, auxiliary material: mountain potassium phosphate 0.05-0.3%, card pool nurse 0.2%~0.5%.
Specific feature of the invention is also:
The nursing bacteriostatic gel is prepared by the component of following quality proportionings: matrine 0.2%, glucan 0.2%, biological peptide
0.1%, hydrolyzed pearl solution 0.01%, bioprotein peptide 0.1%, glue peptide silver-colored 0.2 ‰, palmityl tripeptides -1 0.01%, biotin three
Peptide -10.1%, yeast polypeptides 0.2%, auxiliary material: mountain potassium phosphate 0.05%, card pool nurse 0.2%.
The preparation method of the polypeptide nursing bacteriostatic gel, which comprises the steps of:
S1, appropriate matrine is weighed, matrine is added in the phosphate buffer that pH value is 6.0~7.0 and is dissolved, kuh-seng is obtained
Alkali lysate；
S2, biological peptide, hydrolyzed pearl solution, bioprotein peptide, glue peptide silver, palmityl tripeptides -1, biotin are taken according to quality proportioning
Tripeptides -1, yeast polypeptides, and above-mentioned raw materials are added under agitation in the matrine lysate that step S1 is obtained, it stirs
Appropriate mountain potassium phosphate is added after uniformly；
S3, carbomer and purified water are weighed according to quality proportioning, carbomer is added in purified water under room temperature, impregnate and stir to
Carbomer is completely dissolved, spare；
S4, the mixed solution of step S2 is added in dissolved carbomer solution, and with lactic acid solution adjust pH value be 6.0~
7.0, gelling material is stirred until homogeneous to get nursing bacteriostatic gel, and standing is cooled to room temperature.
S5: being packed into propeller for the nursing gel in step S4 and dispense, ethylene oxide sterilizing.
The nursing bacteriostatic gel is in vaginal cleaning, vagina is antibacterial, the application in vagina anti-inflammatory vagina daily nursing.
The vaginal care gel is pushed into 10~25ml of intravaginal from propeller or is uniformly applied to from vulva.
The invention has the benefit that the present invention is combined using matrine with a variety of biological peptides, it being capable of Fast-Balance yin
Road pH value, analgesia go to itch, it is daily moisten, compact vagina, efficiently maintenance, adjust reproductive system dynamic equilibrium effectively prevent it is various
The effect of gynaecological imflammation, and be easily absorbed by the human body.
Specific embodiment
In order to clarify the technical characteristics of the invention, being illustrated below by specific embodiment to this programme.
Embodiment 1
Polypeptide nursing bacteriostatic gel is prepared by the component of following quality proportionings: matrine 0.2%, glucan 0.2%, biological peptide
0.1%, hydrolyzed pearl solution 0.01%, bioprotein peptide 0.1%, glue peptide silver-colored 0.2 ‰, palmityl tripeptides -1 0.01%, biotin three
Peptide -10.1%, yeast polypeptides 0.2%, auxiliary material: mountain potassium phosphate 0.05, card pool nurse 0.2%.
The preparation method of polypeptide nursing bacteriostatic gel, which comprises the steps of:
S1, appropriate matrine is weighed, matrine is added in the phosphate buffer that pH value is 6.0~7.0 and is dissolved, kuh-seng is obtained
Alkali lysate；
S2, biological peptide, hydrolyzed pearl solution, bioprotein peptide, glue peptide silver, palmityl tripeptides -1, biotin are taken according to quality proportioning
Tripeptides -1, yeast polypeptides, and above-mentioned raw materials are added under agitation in the matrine lysate that step S1 is obtained, it stirs
Appropriate mountain potassium phosphate is added after uniformly；
S3, carbomer and purified water are weighed according to quality proportioning, carbomer is added in purified water under room temperature, impregnate and stir to
Carbomer is completely dissolved, spare；
S4, the mixed solution of step S2 is added in dissolved carbomer solution, and with lactic acid solution adjust pH value be 6.0~
7.0, gelling material is stirred until homogeneous to get nursing bacteriostatic gel, and standing is cooled to room temperature.
S5: being packed into propeller for the nursing gel in step S4 and dispense, ethylene oxide sterilizing.
Embodiment 2
Polypeptide nursing bacteriostatic gel is prepared by the component of following quality proportionings: matrine 0.4%, glucan 0.3%, biological peptide
0.3%, hydrolyzed pearl solution 0.03%, bioprotein peptide 0.25%, glue peptide silver-colored 0.25 ‰, palmityl tripeptides -1 0.03%, biotin three
Peptide -10.03%, yeast polypeptides 0.3%, auxiliary material: mountain potassium phosphate 0.25%, card pool nurse 0.3%.
The preparation method of polypeptide nursing bacteriostatic gel, which comprises the steps of:
S1, appropriate matrine is weighed, matrine is added in the phosphate buffer that pH value is 6.0~7.0 and is dissolved, kuh-seng is obtained
Alkali lysate；
S2, biological peptide, hydrolyzed pearl solution, bioprotein peptide, glue peptide silver, palmityl tripeptides -1, biotin are taken according to quality proportioning
Tripeptides -1, yeast polypeptides, and above-mentioned raw materials are added under agitation in the matrine lysate that step S1 is obtained, it stirs
Appropriate mountain potassium phosphate is added after uniformly；
S3, carbomer and purified water are weighed according to quality proportioning, carbomer is added in purified water under room temperature, impregnate and stir to
Carbomer is completely dissolved, spare；
S4, the mixed solution of step S2 is added in dissolved carbomer solution, and with lactic acid solution adjust pH value be 6.0~
7.0, gelling material is stirred until homogeneous to get nursing bacteriostatic gel, and standing is cooled to room temperature.
S5: being packed into propeller for the nursing gel in step S4 and dispense, ethylene oxide sterilizing.
Embodiment 3
Polypeptide nursing bacteriostatic gel is prepared by the component of following quality proportionings: matrine 0.5%, glucan 0.5%, biological peptide
0.4%, hydrolyzed pearl solution 0.04%, bioprotein peptide 0.4%, glue peptide silver-colored 0.3 ‰, palmityl tripeptides -10.04%, biotin tripeptides -
10.04%, yeast polypeptides 0.5%, auxiliary material: mountain potassium phosphate 0.3%, card pool nurse 0.5%.
The preparation method of polypeptide nursing bacteriostatic gel, which comprises the steps of:
S1, appropriate matrine is weighed, matrine is added in the phosphate buffer that pH value is 6.0~7.0 and is dissolved, kuh-seng is obtained
Alkali lysate；
S2, biological peptide, hydrolyzed pearl solution, bioprotein peptide, glue peptide silver, palmityl tripeptides -1, biotin are taken according to quality proportioning
Tripeptides -1, yeast polypeptides, and above-mentioned raw materials are added under agitation in the matrine lysate that step S1 is obtained, it stirs
Appropriate mountain potassium phosphate is added after uniformly；
S3, carbomer and purified water are weighed according to quality proportioning, carbomer is added in purified water under room temperature, impregnate and stir to
Carbomer is completely dissolved, spare；
S4, the mixed solution of step S2 is added in dissolved carbomer solution, and with lactic acid solution adjust pH value be 6.0~
7.0, gelling material is stirred until homogeneous to get nursing bacteriostatic gel, and standing is cooled to room temperature.
S5: being packed into propeller for the nursing gel in step S4 and dispense, ethylene oxide sterilizing.
Technical characteristic of the present invention without description can realize that details are not described herein by or using the prior art, certainly,
The above description is not a limitation of the present invention, and the present invention is also not limited to the example above, the ordinary skill of the art
The variations, modifications, additions or substitutions that personnel are made within the essential scope of the present invention also should belong to protection model of the invention
It encloses.
Claims (5)
1. a kind of polypeptide nurses bacteriostatic gel, which is characterized in that the bacteriostatic gel of nursing is by the component system of following quality proportionings
It is standby to form: matrine 0.2%~0.5%, glucan 0.2%~0.5%, biological peptide 0.1%~0.4%, hydrolyzed pearl solution 0.01%~
0.04%, bioprotein peptide 0.1%~0.4%, glue peptide silver 0.2-0.3 ‰, palmityl tripeptides -1 0.01%~0.04%, biotin three
Peptide -10.1%~0.04%, yeast polypeptides 0.2%~0.5%, auxiliary material: mountain potassium phosphate 0.05-0.3%, card pool nurse 0.2%~0.5%.
2. polypeptide according to claim 1 nurses bacteriostatic gel, which is characterized in that the nursing bacteriostatic gel is by following matter
The component of amount proportion is prepared: matrine 0.2%, glucan 0.2%, biological peptide 0.1%, hydrolyzed pearl solution 0.01%, biological egg
White peptide 0.1%, glue peptide silver-colored 0.2 ‰, palmityl tripeptides -1 0.01%, biotin tripeptides -10.1%, yeast polypeptides 0.2%, auxiliary material: mountain
Potassium phosphate 0.05%, card pool nurse 0.2%.
3. the preparation method of polypeptide nursing bacteriostatic gel according to claim 2, which comprises the steps of:
S1, appropriate matrine is weighed, matrine is added in the phosphate buffer that pH value is 6.0~7.0 and is dissolved, kuh-seng is obtained
Alkali lysate；
S2, biological peptide, hydrolyzed pearl solution, bioprotein peptide, glue peptide silver, palmityl tripeptides -1, biotin are taken according to quality proportioning
Tripeptides -1, yeast polypeptides, and above-mentioned raw materials are added under agitation in the matrine lysate that step S1 is obtained, it stirs
Appropriate mountain potassium phosphate is added after uniformly；
S3, carbomer and purified water are weighed according to quality proportioning, carbomer is added in purified water under room temperature, impregnate and stir to
Carbomer is completely dissolved, spare；
S4, the mixed solution of step S2 is added in dissolved carbomer solution, and with lactic acid solution adjust pH value be 6.0~
7.0, gelling material is stirred until homogeneous to get nursing bacteriostatic gel, and standing is cooled to room temperature；
S5: being packed into propeller for the nursing gel in step S4 and dispense, ethylene oxide sterilizing.
4. polypeptide according to claim 1-3 nurses bacteriostatic gel, which is characterized in that the nursing bacteriostatic gel
In vaginal cleaning, vagina is antibacterial, the application in vagina anti-inflammatory vagina daily nursing.
5. according to the application of the described in any item polypeptide nursing bacteriostatic gels of claim 4, which is characterized in that protect the vagina
Reason gel is pushed into 10~25ml of intravaginal from propeller or is uniformly applied to from vulva.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910893852.0A CN110464832A (en) | 2019-09-20 | 2019-09-20 | A kind of polypeptide nursing bacteriostatic gel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910893852.0A CN110464832A (en) | 2019-09-20 | 2019-09-20 | A kind of polypeptide nursing bacteriostatic gel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110464832A true CN110464832A (en) | 2019-11-19 |
Family
ID=68516385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910893852.0A Pending CN110464832A (en) | 2019-09-20 | 2019-09-20 | A kind of polypeptide nursing bacteriostatic gel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110464832A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112353866A (en) * | 2020-11-21 | 2021-02-12 | 陕西远志医药生物工程有限公司 | Polypeptide nursing antibacterial gel and preparation method thereof |
| CN113730433A (en) * | 2021-09-30 | 2021-12-03 | 湖南天根乐微君科技有限公司 | Gynecological gel and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729655A (en) * | 2016-11-18 | 2017-05-31 | 珠海市新辅仁药业有限公司 | A kind of bacteriostatic gel and preparation method thereof |
| CN107952059A (en) * | 2017-12-21 | 2018-04-24 | 广州赛美药业有限公司 | A kind of gynaecology's bacteriostatic gel and preparation method thereof |
| CN109010529A (en) * | 2018-07-30 | 2018-12-18 | 苏州美稀生物科技有限公司 | A kind of Traditional Chinese medicine bacteriostatic gelling agent for vagina nursing |
| CN110151981A (en) * | 2019-05-31 | 2019-08-23 | 杨平芝 | A kind of composition and preparation method thereof repaired vagina and treat vaginitis |
-
2019
- 2019-09-20 CN CN201910893852.0A patent/CN110464832A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729655A (en) * | 2016-11-18 | 2017-05-31 | 珠海市新辅仁药业有限公司 | A kind of bacteriostatic gel and preparation method thereof |
| CN107952059A (en) * | 2017-12-21 | 2018-04-24 | 广州赛美药业有限公司 | A kind of gynaecology's bacteriostatic gel and preparation method thereof |
| CN109010529A (en) * | 2018-07-30 | 2018-12-18 | 苏州美稀生物科技有限公司 | A kind of Traditional Chinese medicine bacteriostatic gelling agent for vagina nursing |
| CN110151981A (en) * | 2019-05-31 | 2019-08-23 | 杨平芝 | A kind of composition and preparation method thereof repaired vagina and treat vaginitis |
Non-Patent Citations (1)
| Title |
|---|
| 刘东泽 等: "苦参凝胶药理作用与临床研究进展", 《上海中医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112353866A (en) * | 2020-11-21 | 2021-02-12 | 陕西远志医药生物工程有限公司 | Polypeptide nursing antibacterial gel and preparation method thereof |
| CN113730433A (en) * | 2021-09-30 | 2021-12-03 | 湖南天根乐微君科技有限公司 | Gynecological gel and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI469786B (en) | Agent for treating infectious skin disease and mucosal disease | |
| CN110464811A (en) | A kind of gynaecology's foam antibacterial liquid and preparation method thereof | |
| US20110178488A1 (en) | Sexual Hygienic Composition | |
| CN110464832A (en) | A kind of polypeptide nursing bacteriostatic gel | |
| CN110604810A (en) | Hydrolyzed collagen gel for gynecology and preparation method thereof | |
| CN103316262B (en) | A kind of gynecological external antibacterial liquid and preparation method thereof | |
| CN110917120A (en) | Sticky antibacterial repairing material and preparation method and application thereof | |
| US6770306B1 (en) | Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof | |
| CN100502953C (en) | Wound surface active repairing material | |
| CN107811964A (en) | Antibacterial conception control gel that is biodegradable and realizing dosed administration | |
| KR101924894B1 (en) | Skin ointment for treating skin of the labia minora | |
| CN109602874A (en) | A kind of gynaecology's gel comprising dendrobium nobile, peony extract | |
| CN100348202C (en) | Oral compound preparation for treating skin disease | |
| CN101766813A (en) | Suppository for treating mammalian endometritis and preparation method thereof | |
| US7262170B2 (en) | Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof | |
| CN107551090A (en) | One kind, which is nourished, repairs gel | |
| CN100584376C (en) | Medicine for treating deep erosive trauma with crust | |
| CN100388949C (en) | Lysostaphin freeze dried powder used for preventing and treating cattle edometritis | |
| CN110179840A (en) | A kind of cordyceps sinensis vagina anti-immunity bacteriostatic agent and preparation method thereof | |
| CN106177274A (en) | A kind of conception control gel composition and preparation method thereof | |
| CN112870311A (en) | Female private part antibacterial hydrogel and using method thereof | |
| CN109602762A (en) | A kind of combination medicine for treating gerontal patient's incontinence correlation dermatitis | |
| CN103520707B (en) | A kind of beneficial bacterium controls the compositions that bacterium prevention and therapy gynaecologic reproductive system infects | |
| CN103127388B (en) | A kind of biological controlled-released film formulation and biological controlled-released film production process thereof | |
| RU2113183C1 (en) | Method of treatment of bacterial vaginosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191119 |
|
| RJ01 | Rejection of invention patent application after publication |